Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yamaji, Toshiyuki ^a   Hanada, Kentaro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CERAMIDE GLUCOSYLTRANSFERASE; LACTOSYLCERAMIDE; NUCLEASE; SPHINGOLIPID; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELLULAR DISTRIBUTION; GENE DISRUPTION; GENETIC CODE; HELA CELL; HUMAN; KARYOTYPE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; TRIPLOIDY;

ANIMALS; BASE SEQUENCE; CATIONIC AMINO ACID TRANSPORTER 1; DEOXYRIBONUCLEASES; GALACTOSYLTRANSFERASES; GLUCOSYLTRANSFERASES; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPHINGOLIPIDS;

EID: 84894627942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088124     Document Type: Article

References (60)

1. Hanada K, Nishijima M, Kiso M, Hasegawa A, Fujita S, et al. (1992) Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. J Biol Chem 267:23527-23533. (Pubitemid 23088151)
2. Pinto WJ, Wells GW, Lester RL (1992) Characterization of enzymatic synthesis of sphingolipid long-chain bases in Saccharomyces cerevisiae: mutant strains exhibiting long-chain-base auxotrophy are deficient in serine palmitoyltransferase activity. J Bacteriol 174: 2575-2581.
3. Adachi-Yamada T, Gotoh T, Sugimura I, Tateno M, Nishida Y, et al. (1999) De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol Cell Biol 19: 7276-7286. (Pubitemid 29441907)
4. Hakomori S (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780: 325-346.
5. Chen Y, Liu Y, Sullards MC, Merrill AH Jr (2010) An introduction to sphingolipid metabolism and analysis by new technologies. Neuromolecular Med 12: 306-319.
6. Wennekes T, van den Berg RJ, Boot RG, van der Marel GA, Overkleeft HS, et al. (2009) Glycosphingolipids-nature, function, and pharmacological modulation. Angew Chem Int Ed Engl 48: 8848-8869.
7. Furukawa K, Ohmi Y, Ohkawa Y, Tokuda N, Kondo Y, et al. (2011) Regulatory mechanisms of nervous systems with glycosphingolipids. Neurochem Res 36: 1578-1586.
8. Proia R (2003) Glycosphingolipid functions: insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci 538: 879-883.
9. Inokuchi J (2011) Physiopathological function of hematoside (GM3 ganglioside). Proc Jpn Acad Ser B Phys Biol Sci 87: 179-198.
10. Russo SB, Ross JS, Cowart LA (2013) Sphingolipids in obesity, type 2 diabetes, and metabolic disease. Handb Exp Pharmacol 216: 373-401.
11. Hla T, Dannenberg AJ (2012) Sphingolipid signaling in metabolic disorders. Cell Metab 16: 420-434.
12. Inokuchi J (2010) Membrane microdomains and insulin resistance. FEBS Lett 584: 1864-1871.
13. van Echten-Deckert G, Walter J (2012) Sphingolipids: critical players in Alzheimer's disease. Prog Lipid Res 51: 378-393.
14. Yanagisawa K (2011) Pathological significance of ganglioside clusters in Alzheimer's disease. J Neurochem 116: 806-812.
15. Hanada K (2005) Sphingolipids in infectious diseases. Jpn J Infect Dis 58: 131-148.
16. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, et al. (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426: 803-809. (Pubitemid 38056858)
17. Yamaji T, Kumagai K, Tomishige N, Hanada K (2008) Two sphingolipid transfer proteins, CERT and FAPP2: their roles in sphingolipid metabolism. IUBMB Life 60: 511-518.
18. Giussani P, Brioschi L, Bassi R, Riboni L, Viani P (2009) Phosphatidylinositol 3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traffic of ceramide in glioma cells: a link between lipid signaling pathways involved in the control of cell survival. J Biol Chem 284: 5088-5096.
19. Gillon A, Latham CF, Miller EA (2012) Vesicle-mediated ER export of proteins and lipids. Biochim Biophys Acta 1821: 1040-1049.
20. Kawano M, Kumagai K, Nishijima M, Hanada K (2006) Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT. J Biol Chem 281: 30279-30288. (Pubitemid 44537035)
21. Ichikawa S, Nakajo N, Sakiyama H, Hirabayashi Y (1994) A mouse B16 melanoma mutant deficient in glycolipids. Proc Natl Acad Sci U S A 91: 2703-2707. (Pubitemid 24139416)
22. Trinchera M, Fabbri M, Ghidoni R (1991) Topography of glycosyltransferases involved in the initial glycosylations of gangliosides. J Biol Chem 266: 20907-20912 (Pubitemid 21908550)
23. Futerman AH, Pagano RE (1991) Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem J 280: 295-302
24. Lannert H, Bünning C, Jeckel D, Wieland FT (1994) Lactosylceramide is synthesized in the lumen of the Golgi apparatus. FEBS Lett 342: 91-96 (Pubitemid 24101400)
25. Kumagai T, Sato T, Natsuka S, Kobayashi Y, Zhou D, et al. (2010) Involvement of murine beta-1,4-galactosyltransferase V in lactosylceramide biosynthesis. Glycoconj J 27: 685-695.
26. Nishie T, Hikimochi Y, Zama K, Fukusumi Y, Ito M, et al. (2010) Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 20: 1311-1322.
27. Tokuda N, Numata S, Li X, Nomura T, Takizawa M, et al. (2013) β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. Glycobiology 23: 1175-1183.
28. Wang X, Rao RP, Kosakowska-Cholody T, Masood MA, Southon E, et al. (2009) Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol 184: 143-158.
29. Yamashita T, Wada R, Sasaki T, Deng C, Bierfreund U, et al. (1999) A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A 96: 9142-9147. (Pubitemid 29374721)
30. Kumagai T, Tanaka M, Yokoyama M, Sato T, Shinkai T, et al. (2009) Early lethality of beta-1,4-galactosyltransferase V-mutant mice by growth retardation. Biochem Biophys Res Commun 379: 456-459
31. Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Research 12: 264-265
32. Akiyama S (1987) HeLa cell lines. Methods Enzymol 151: 38-50
33. Scherer WF, Syveron JT, Gey GO (1953) Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 97:695-710
34. Mitsui Y, Kitamuro T, Endo K, Matsumura K (1964) Trachoma and inclusion conjunctivitis agents: Adaptation to HeLa Cell Cultures. Science 145: 715-716
35. Landry J, Pyl PT, Rausch T, Zichner T, Tekkedil MM, et al. (2013) The Genomic and Transcriptomic Landscape of a HeLa Cell Line. G3 (Bethesda) 3: 1213-1224.
36. Adey A, Burton JN, Kitzman JO, Hiatt JB, Lewis AP, et al. (2013) The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature 500: 207-211.
37. Hanada K (2003) Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 1632:16-30
38. Hanada K, Kumagai K, Tomishige N, Yamaji T (2009) CERT-mediated trafficking of ceramide. Biochim Biophys Acta 1791: 684-691
39. Yamaji T, Nishikawa K, Hanada K (2010) Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis. J Biol Chem 285: 35505-35518.
40. Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, et al. (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186: 757-761.
41. Miller J, Tan S, Qiao G, Barlow KA, Wang J, et al. (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29: 143-148.
42. Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, et al. (2011) A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39: 9283-9293.
43. Cade L, Reyon D, Hwang WY, Tsai SQ, Patel S, et al. (2012) Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Res 40: 8001-8010.
44. Guo J, Gaj T, Barbas CF 3rd (2010) Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400: 97-107.
45. Doyon Y, Choi VM, Xia DF, Vo TD, Gregory PD, et al. (2010) Transient cold shock enhances zinc-finger nuclease-mediated gene disruption. Nat Methods 7: 459-460.
46. Albritton L, Tseng L, Scadden D, Cunningham JM (1989) A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57: 659-666. (Pubitemid 19140646)
47. Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, et al. (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39: e82.
48. Doyle E, Booher NJ, Standage DS, Voytas DF, Brendel VP, et al. (2012) TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction. Nucleic Acids Res 40: W117-122.
49. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066. (Pubitemid 30398356)
50. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15: 7-12.
51. Carlson D, Tan W, Lillico SG, Stverakova D, Proudfoot C, et al. (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A 109: 17382-17387.
52. Yamaji A, Sekizawa Y, Emoto K, Sakuraba H, Inoue K, et al. (1998) Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem 273: 5300-5306. (Pubitemid 28108696)
53. Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, et al. (2010) ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc Natl Acad Sci U S A 107:18439-18444.
54. Zaima N, Goto-Inoue N, Adachi K, Setou M (2011) Selective analysis of lipids by thin-layer chromatography blot matrix-assisted laser desorption/ionization imaging mass spectrometry. J Oleo Sci 60: 93-98.
55. Marks D, Dominguez M, Wu K, Pagano RE (2001) Identification of active site residues in glucosylceramide synthase. A nucleotide-binding catalytic motif conserved with processive beta-glycosyltransferases. J Biol Chem 276: 26492-26498.
56. Hanada K (2013) Co-evolution of sphingomyelin and the ceramide transport protein CERT. Biochim Biophys Acta S1388-1981.
57. Nomura T, Takizawa M, Aoki J, Arai H, Inoue K, et al. (1998) Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain. J Biol Chem 273: 13570-13577. (Pubitemid 28268399)
58. Fukasawa M, Nishijima M, Hanada K (1999) Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J Cell Biol 144: 673-685. (Pubitemid 29234546)
59. Funakoshi T, Yasuda S, Fukasawa M, Nishijima M, Hanada K (2000) Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J Biol Chem 275: 29938-29945.
60. Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, et al. (2005) CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 280: 6488-6495 (Pubitemid 40341197)